Whole Grains, Gastric Emptying and Glycemic Response

NCT03467659 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 16

Last updated 2018-03-19

No results posted yet for this study

Summary

Whole grains have been associated with controlled glycemic response and increased satiety compared to refined grains. However, the properties of whole grains which are responsible for these purported improved health outcomes are still unclear. The current study investigated the extent of whole grains' low glycemic property when food properties are controlled, and how this relates to gastric emptying rate and glycemic response.

Conditions

  • Obesity
  • Diabetes Mellitus, Type 2
  • Appetitive Behavior

Interventions

OTHER

Cracked whole wheat porridge

Large particle whole wheat porridge was tested for gastric emptying rate, glycemic response and appetitive response.

OTHER

Semolina wheat porridge

Large particle refined wheat porridge was tested for gastric emptying rate, glycemic response and appetitive response.

OTHER

Whole wheat flour porridge

Small particle whole wheat porridge was tested for gastric emptying rate, glycemic response and appetitive response.

OTHER

Refined wheat flour porridge

Small particle refined wheat porridge was tested for gastric emptying rate, glycemic response and appetitive response.

OTHER

Refined wheat flour porridge,fine bran

Small particle refined wheat porridge with small particle bran was tested for gastric emptying rate, glycemic response and appetitive response.

OTHER

Refined wheat flour porridge,coarse bran

Small particle refined wheat porridge with large particle bran was tested for gastric emptying rate, glycemic response and appetitive response.

Sponsors & Collaborators

  • Purdue University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-02-16
Primary Completion
2017-05-31
Completion
2017-05-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03467659 on ClinicalTrials.gov